TMED Fact Sheet: T. Rowe Price Health Care ETF
Share
$33.12
close, Nov 18, 2026
Over the year to Nov 18, 2026, TMED returned +13.6% in total and charged 0.44% a year.
- 1-year total return
- +13.6%
- XLV +20.7% to Nov 18, 2026
- Expense ratio
- 0.44%
- a year
- Net assets
- $41m
- on Nov 17, 2026
- Net flow, last 2 trading days
- +$3.5m
- daily basis to Nov 16, 2026
Growth of $10,000, 1 year
TMED $11,355 +13.6% · XLV $12,070 +20.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−1.3%
3 months−9.7%
Year to date+11.4%
1 year+13.6%
Since launch+32.5%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
ELI LILLY & CO16.71%
UNITEDHEALTH GROUP INC6.52%
GILEAD SCIENCES INC4.43%
THERMO FISHER SCIENTIFIC INC4.12%
DANAHER CORP2.96%
CENCORA INC2.75%
AGILENT TECHNOLOGIES INC2.61%
ALNYLAM PHARMACEUTICALS INC2.60%
INTUITIVE SURGICAL INC2.44%
INSULET CORP2.38%
TMED top ten by weight, 47.5% of the fund, of its 96 equity positions, from the holdings filed for Jun 30, 2026.
Facts
Equity fund · Actively managed · First traded Jun 12, 2025 · Benchmark S&P Health Care Select Sector Index, measured by XLV, which tracks the same index